Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II).

Christian Gratzke,Rob van Maanen,Christopher Chapple,Paul Abrams,Sender Herschorn,Dudley Robinson,Arwin Ridder,Matthias Stoelzel,Asha Paireddy,Sang Jin Yoon, Salman Al-Shukri,Tomasz Rechberger,Elizabeth R Mueller

European Urology（2018）

引用 87|浏览19

暂无评分

摘要

Mirabegron and solifenacin combination treatment for overactive bladder symptoms has a favourable long-term safety and efficacy profile. This observation suggests that the regimen may constitute a novel treatment option for overactive bladder.

查看译文

关键词

Combination,Efficacy,Long-term treatment,Mirabegron,Overactive bladder,Safety,Solifenacin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要